Solara™ cardiac resynchonization pacemaker (CRT-P) MRI SureScan™ shown at front-facing angle

CRT-Ps

Solara™ CRT-P MRI SureScan™

<p>Solara™ CRT-Ps are enabled with BlueSync™ technology, allowing for tablet-based programming and app-based remote monitoring.</p>

Ordering information

Contact a representative

Indications, Safety, and WarningsThe material on this website should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s).Please note that the intended use of a product may vary depending on geographical approvals.See the device manual(s) for detailed information regarding the intended use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events.For a MRI compatible device(s), consult the MRI information in the device manual(s) before performing a MRI.If a device is eligible for eIFU usage, instructions for use can be found at the Medtronic website manuals.medtronic.com.Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.Medtronic products placed on European markets comply with EU and UK legislation (if applicable) on medical devices. For any further information, contact your local Medtronic representative.Medtronic medical devices marketed in Spain are in compliance with the Spanish legislation in force.

Unmatched feature suite

Enhanced longevity 

The estimated longevity of Solara^TM CRT-P MRI SureScan^TM is 11 years*.

*@ 2.5.V/2.V/2.5V, 600Ω, 15%AP, 50%RV, 100%LV

PhysioCurve™ design for patient comfort 

Tapered at the head and bottom of device to reduce skin pressure and promote patient comfort
Designed with lead wrap in mind — landing area to minimize additional stresses on the lead¹

Learn about Solara™ CRT-Ps for heart failure management.

Reimagined connectivity with BlueSync™ technology 

Solara™ CRT-Ps with BlueSync™ technology enable secure, wireless communication. 

CareLink SmartSync™ interface shown on tablet

Tablet-based CareLink SmartSync™ device manager

Indications, Safety, and WarningsIndications  The Solara™ CRT-P MRI SureScan™ system is indicated for NYHA functional class III and IV patients who remain symptomatic despite stable, optimal heart failure medical therapy and have LVEF ≤ 35% and a prolonged QRS duration and for NYHA functional class I, II, or III patients who have LVEF ≤ 50%, are on stable, optimal heart failure medical therapy if indicated and have atrioventricular block (AV block) that are expected to require a high percentage of ventricular pacing that cannot be managed with algorithms to minimize right ventricular pacing. Optimization of heart failure medical therapy that is limited due to AV block or the urgent need for pacing should be done post-implant. Rate adaptive pacing is provided for those patients developing a bradycardia indication who might benefit from increased pacing rates concurrent with increases in activity. Dual chamber and atrial tracking modes are indicated for patients who may benefit from maintenance of AV synchrony. Antitachycardia pacing (ATP) is indicated for termination of atrial tachyarrhythmias in patients with one or more of the above pacing indications. A complete SureScan™ pacing system is required for use in the MR environment. A complete SureScan™ pacing system includes a SureScan™ device with Medtronic SureScan™ leads or a Model 6725 pin plug for the right atrial port.Contraindications  The Solara™ CRT-P MRI SureScan™ system is contraindicated for concomitant implant with another bradycardia device and concomitant implant with an implantable cardioverter defibrillator. There are no known contraindications for the use of pacing as a therapeutic modality to control heart rate. The patient’s age and medical condition, however, may dictate the particular pacing system, mode of operation, and implant procedure used by the physician. Rate-responsive modes may be contraindicated in those patients who cannot tolerate pacing rates above the programmed “lower rate.” Dual chamber sequential pacing is contraindicated in patients with chronic or persistent supraventricular tachycardias, including atrial fibrillation or flutter. Asynchronous pacing is contraindicated in the presence (or likelihood) of competition between paced and intrinsic rhythms. Single chamber atrial pacing is contraindicated in patients with an AV conduction disturbance. Antitachycardia pacing (ATP) therapy is contraindicated in patients with an accessory antegrade pathway. Warnings and precautions  A complete SureScan™ pacing system is required for use in the MR environment. Before performing an MRI scan, refer to the MRI technical manual for MRI-specific warnings and precautions. A complete SureScan™ pacing system includes a SureScan™ device with Medtronic SureScan™ leads or a Model 6725 pin plug for the right atrial port. Any other combination may result in a hazard to the patient during an MRI scan. Changes in a patient’s disease and/or medications may alter the efficacy of the device’s programmed parameters. Patients should avoid sources of magnetic and electromagnetic radiation to avoid possible underdetection, inappropriate sensing and/or therapy delivery, tissue damage, induction of an arrhythmia, device electrical reset, or device damage. Do not place transthoracic defibrillation paddles directly over the device. Certain programming and device operations may not provide cardiac resynchronization. Elective replacement indicator (ERI) results in the device switching to VVI pacing at 65 ppm. In this mode, patients may experience loss of cardiac resynchronization therapy and/or loss of AV synchrony. For this reason, the device should be replaced prior to ERI being set. Use of the device should not change the application of established anticoagulation protocols. Patients and their implanted systems must be screened to meet the following requirements for MRI: no implanted lead extenders, lead adaptors, or abandoned leads; no broken leads or leads with intermittent electrical contact as confirmed by lead impedance history; a SureScan pacing system implanted in the left or right pectoral region. Additionally, for patients whose device will be programmed to an asynchronous pacing mode when MRI SureScan™ is programmed to “on,” no diaphragmatic stimulation is present at a pacing output of 5.0 V and at a pulse width of 1.0 ms. Potential adverse events  Potential complications include, but are not limited to, rejection phenomena, erosion through the skin, muscle or nerve stimulation, oversensing, failure to detect and/or terminate arrhythmia episodes, and surgical complications such as hematoma, infection, inflammation, and thrombosis. Other potential complications related to the lead may include lead dislodgement, lead conductor fracture, insulation failure, threshold elevation, or exit block. Potential MRI complications for the SureScan™ system include, but are not limited to, lead electrode heating and tissue damage resulting in loss of sensing or capture or both, or MRI-induced currents on leads resulting in continuous capture, VT/VF, and/or hemodynamic collapse; spontaneous tachyarrhythmia occurring during the scan that is not detected and treated because tachyarrhythmia detection is suspended while MRI SureScan™ is programmed to “on”; potential for VT/VF induction when the patient is programmed to an asynchronous pacing mode during MRI SureScan™; device heating resulting in tissue damage in the implant pocket or patient discomfort or both; or damage to the functionality or mechanical integrity of the device resulting in the inability of the device to communicate with the programmer. See the appropriate Solara™ product device manuals for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. See the appropriate Solara™ product MRI SureScan™ technical manual before performing an MRI scan.Caution: Federal law (United States) restricts these devices to sale by or on the order of a physician. MAJ_82690

Image of Solara™ Quad CRT-P MRI SureScan™ and Solara™ CRT-P MRI SureScan™ with BlueSync™ icon

Solara™ CRT-Ps and
Solara™ Quad CRT-Ps

MyCareLink Heart™ app and MyCareLink Relay™ home communicator on white background

MyCareLink Heart™ mobile app or MyCareLink Relay™ Communicator

View the Get Connected service shown on a desktop monitor.

CareLink™ network and the
Get Connected™ service

Streamlined heart failure management with CareAlert™ notifications 

Time to a clinical decision was about seven times faster with the use of Medtronic CareAlert™ notifications compared to standard office follow-up.² 

Clinical management alerts: 

Atrial tachyarrhythmia / atrial fibrillation (AT/AF) daily burden enable 
Average ventricular rate during AT/AF 
Monitored ventricular tachyarrhythmia (VT) episode 
Ventricular pacing < 90%

Device management alerts:

Low battery voltage recommended replacement time (RRT) 
Atrial pacing enable  
Right-ventricular (RV) pacing enable  
Left-ventricular (LV) pacing enable  
Atrial capture enable  
RV capture enable  
LV capture enable

System features and exclusive algorithms

Quadripolar models:

Multiple point pacing  
OptiVol™ 2.0 fluid status monitoring  
BlueSync™ technology   
MRI SureScan™ technology  
PhysioCurve™ design  
Attain™ Performa™ advanced quadripolar lead and VectorExpress™ LV automated test

Bipolar models:   

OptiVol™ 2.0 fluid status monitoring 
BlueSync™ technology  
MRI SureScan™ technology 
PhysioCurve™ design

Ordering information

Solara™ CRT-P MRI

Item number	Mass (g)	Volume (mL)	Size — height × width × depth (mm)	Connector
W1TR06	30	20	59 × 46.5 × 11	3x IS-1

Solara™ Quad CRT-P MRI

Item number	Mass (g)	Volume (mL)	Size — height × width × depth (mm)	Connector
W4TR06	30	20.5	59 × 46.5 × 11	2x IS-1 / 1x IS-4

Solara™ CRT-P MRI SureScan™

Unmatched feature suite

Enhanced longevity

PhysioCurve™ design for patient comfort

Reimagined connectivity with BlueSync™ technology

Streamlined heart failure management with CareAlert™ notifications

Clinical management alerts:

Device management alerts:

System features and exclusive algorithms

Quadripolar models:

Bipolar models:

Ordering information

Solara™ CRT-P MRI

Solara™ Quad CRT-P MRI

Similar products

Enhanced longevity 

PhysioCurve™ design for patient comfort 

Reimagined connectivity with BlueSync™ technology 

Streamlined heart failure management with CareAlert™ notifications 

Clinical management alerts: 

Bipolar models:   